Health & Medicine · Clinical Dosing · Antibiotic Dosing
Gentamicin Dosing Calculator
Calculates extended-interval (once-daily) and traditional gentamicin dosing based on patient weight, renal function, and indication.
Calculator
Formula
Dose (mg): total gentamicin dose administered. D_mg/kg: weight-based dose in mg/kg (5–7 mg/kg for once-daily; 1.5–2.5 mg/kg for traditional). W_dosing: dosing weight — actual body weight if ≤ IBW, or adjusted body weight (ABW) if obese. IBW: ideal body weight calculated by the Devine formula using height in inches (H_in). CrCl: creatinine clearance estimated via the Cockcroft-Gault equation using age, dosing weight, and serum creatinine (S_Cr). Dosing interval is adjusted based on CrCl to prevent nephrotoxicity and ototoxicity.
Source: Cockcroft DW & Gault MH (1976). Nephron 16:31–41. Devine BJ (1974). Drug Intelligence & Clinical Pharmacy. Nicolau DP et al. (1995). Antimicrob Agents Chemother 39(3):650–655.
How it works
Gentamicin exhibits concentration-dependent bactericidal activity, meaning higher peak concentrations relative to the minimum inhibitory concentration (MIC) produce greater bacterial killing. This pharmacodynamic property underpins the rationale for once-daily (extended-interval) dosing, where a larger single dose is administered every 24 to 48 hours depending on renal function, rather than smaller doses given every 8 hours in traditional regimens. Once-daily dosing maximizes the peak-to-MIC ratio while allowing a trough period that reduces accumulation in renal tubular cells, thereby lowering nephrotoxicity risk.
Dosing relies on three key calculations. First, ideal body weight (IBW) is determined using the Devine formula based on height and sex. If the patient's actual body weight exceeds IBW by more than 20% (obesity threshold), an adjusted body weight (ABW) is used: ABW = IBW + 0.4 × (Actual weight − IBW). This correction accounts for the partial distribution of aminoglycosides into adipose tissue. Second, creatinine clearance (CrCl) is estimated via the Cockcroft-Gault equation using age, dosing weight, serum creatinine, and a 0.85 correction factor for females. CrCl drives interval selection: ≥60 mL/min supports q24h dosing, 40–59 mL/min supports q36h, and <40 mL/min generally requires individualized therapeutic drug monitoring (TDM) rather than standard extended-interval protocols. Third, the dose in mg/kg is multiplied by the dosing weight to yield the total dose in milligrams.
The calculator supports three indications: standard gram-negative infections typically dosed at 7 mg/kg once daily, urinary tract infections often at 5 mg/kg, and synergy dosing for endocarditis or enterococcal infections using traditional 1–1.5 mg/kg every 8 hours. All results should be reviewed by a qualified clinician, and therapeutic drug monitoring is strongly recommended for patients receiving multiple doses.
Worked example
Consider a 58-year-old male patient who is 178 cm tall, weighs 95 kg, and has a serum creatinine of 1.2 mg/dL. He has a suspected gram-negative bacteremia, and once-daily extended-interval dosing is planned.
Step 1 — Ideal Body Weight: Height in inches = 178 ÷ 2.54 = 70.1 inches. IBW (male) = 50 + 2.3 × (70.1 − 60) = 50 + 23.2 = 73.2 kg.
Step 2 — Dosing Weight: Actual weight (95 kg) exceeds IBW (73.2 kg) by more than 20% (obesity threshold = 73.2 × 1.2 = 87.8 kg). Use ABW = 73.2 + 0.4 × (95 − 73.2) = 73.2 + 8.7 = 81.9 kg.
Step 3 — Creatinine Clearance: CrCl = [(140 − 58) × 81.9] / [72 × 1.2] = [82 × 81.9] / 86.4 = 6715.8 / 86.4 = 77.7 mL/min (no female correction needed).
Step 4 — Dose Calculation: For standard gram-negative infection once-daily dosing, use 7 mg/kg. Total dose = 7 × 81.9 = 573 mg (rounded to nearest 10 mg in clinical practice → 570–580 mg).
Step 5 — Interval: CrCl ≥ 60 mL/min → administer every 24 hours.
Summary: Gentamicin ~570–580 mg IV every 24 hours. Obtain a 6–14 hour post-dose level to guide subsequent dosing via the Hartford nomogram. Monitor serum creatinine daily.
Limitations & notes
This calculator is a clinical decision-support tool only and does not replace individualized pharmacokinetic assessment or professional judgment. Extended-interval dosing is generally contraindicated in patients with CrCl below 20 mL/min, those on renal replacement therapy, pregnant patients, patients with burns over more than 20% of body surface area, endocarditis (where synergy dosing is preferred), and patients with ascites or other conditions causing significant third-spacing. The Cockcroft-Gault equation may overestimate CrCl in elderly, malnourished, or edematous patients where muscle mass is reduced relative to body weight; in such cases, using actual body weight or capping serum creatinine at 1.0 mg/dL may be considered per institutional protocol. The calculator does not account for cystic fibrosis pharmacokinetics, which require substantially higher doses. All calculated doses should be rounded to a clinically practical value, and therapeutic drug monitoring (serum trough and/or peak levels) is mandatory for any patient receiving more than a single dose. Patients with rapidly changing renal function require reassessment before each dose.
Frequently asked questions
What is the difference between once-daily and traditional gentamicin dosing?
Once-daily (extended-interval) dosing administers a larger dose (5–7 mg/kg) every 24–48 hours to maximize peak bactericidal effect and allow a drug-free trough period that reduces renal tubular accumulation. Traditional dosing uses smaller doses (1–2.5 mg/kg) every 8 hours and is preferred for specific indications like synergy dosing in endocarditis. Once-daily dosing has largely replaced traditional dosing for most gram-negative infections due to equivalent or superior efficacy and lower nephrotoxicity rates.
Why is adjusted body weight used for obese patients?
Aminoglycosides are hydrophilic and distribute primarily into lean body mass, not fat. However, adipose tissue does contain some extracellular water into which gentamicin partially distributes. Using actual body weight in obese patients would overestimate the volume of distribution and lead to supratherapeutic doses. The adjusted body weight formula (IBW + 0.4 × excess weight) corrects for the partial distribution into fat, striking a balance between underdosing and toxicity risk.
What serum levels should be monitored with gentamicin?
For once-daily dosing, a random level drawn 6–14 hours after the dose is plotted on the Hartford nomogram to confirm appropriate dosing. Levels should be undetectable (<1 mg/L) before the next dose to minimize toxicity. For traditional dosing, peak levels (30 minutes post-infusion) should target 5–10 mg/L for most infections (higher for serious sepsis) and trough levels should remain below 2 mg/L. Peaks and troughs are essential for traditional dosing therapeutic drug monitoring.
When should gentamicin extended-interval dosing NOT be used?
Extended-interval dosing is contraindicated or requires special consideration in patients with CrCl below 20 mL/min, those receiving dialysis, pregnant women (increased volume of distribution and altered clearance), patients with burns exceeding 20% BSA, those with endocarditis or enterococcal infections (synergy dosing is preferred), and patients with significant ascites or anasarca. In these populations, traditional dosing with careful TDM or specialist consultation is recommended.
How does gentamicin cause nephrotoxicity and how is it minimized?
Gentamicin accumulates in proximal renal tubular cells via endocytosis, where it disrupts lysosomal function and mitochondrial metabolism, causing tubular cell necrosis. Risk is highest with prolonged trough exposure (high troughs), volume depletion, concurrent nephrotoxic agents (NSAIDs, vancomycin, contrast), and pre-existing renal impairment. Extended-interval dosing minimizes toxicity by allowing a drug-free window where tubular cells can recover. Ensuring adequate hydration, avoiding concurrent nephrotoxins, and monitoring creatinine daily are key preventive strategies.
Last updated: 2025-01-15 · Formula verified against primary sources.